Log in to save to my catalogue

Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a st...

Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a st...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9578e48a95d1476c92f94515f34c571f

Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention

About this item

Full title

Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2023-07, Vol.25 (1), p.131-131, Article 131

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Patients with psoriatic arthritis (PsA) are frequently obese. We have previously shown decreased disease activity in patients with PsA with a body mass index (BMI) ≥ 33 kg/m
following weight loss treatment with Very Low Energy Diet (VLED), resulting in a median weight loss of 18.6% at six months (M6) after baseline (BL). In this study we assesse...

Alternative Titles

Full title

Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9578e48a95d1476c92f94515f34c571f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9578e48a95d1476c92f94515f34c571f

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-023-03105-8

How to access this item